INOZYME PHARMA INC filings

All
Holdings
Significant ownership
Insider transactions
Annual reports
Quarterly reports
Events
Shareholder votes
SEC filings by INOZYME PHARMA INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13D/A2024-02-20Sofinnova Venture Partners X, L.P.Inozyme Pharma, Inc.4,280,3086.9%EDGAR
SC 13G/A2024-02-14New Enterprise Associates 15, L.P.Inozyme Pharma, Inc.--EDGAR
SC 13G/A2024-02-14BAKER BROS. ADVISORS LPInozyme Pharma, Inc.-0.0%EDGAR
SC 13G/A2024-02-14Venrock Healthcare Capital Partners II, L.P.Inozyme Pharma, Inc.00.0%EDGAR
SC 13G/A2024-02-14Deep Track Capital, LPInozyme Pharma, Inc.00.0%EDGAR
SC 13G/A2024-02-14Rock Springs Capital Management LPInozyme Pharma, Inc.3,681,1746.0%EDGAR
SC 13G2024-02-14SAMLYN CAPITAL, LLCInozyme Pharma, Inc.3,372,5585.5%EDGAR
SC 13G2024-02-14EVENTIDE ASSET MANAGEMENT, LLCInozyme Pharma, Inc.3,179,8375.2%EDGAR
SC 13D/A2024-02-12Pivotal bioVenture Partners Fund I, L.P.Inozyme Pharma, Inc.2,923,1104.7%EDGAR
SC 13G/A2024-02-07ADAGE CAPITAL PARTNERS GP, L.L.C.Inozyme Pharma, Inc.5,537,5009.0%EDGAR
SC 13G/A2024-02-05SPHERA FUNDS MANAGEMENT LTD.Inozyme Pharma, Inc.1,562,9072.5%EDGAR
SC 13G/A2024-01-16MILLENNIUM MANAGEMENT LLCInozyme Pharma, Inc.911,4651.5%EDGAR
SC 13D/A2023-08-11Longitude Capital Partners III, LLCInozyme Pharma, Inc.4,174,3797.1%EDGAR
SC 13D/A2023-08-08Pivotal bioVenture Partners Fund I, L.P.Inozyme Pharma, Inc.2,923,1106.2%EDGAR
SC 13G2023-05-31MILLENNIUM MANAGEMENT LLCInozyme Pharma, Inc.2,292,8275.2%EDGAR
SC 13D/A2023-05-23Pivotal bioVenture Partners Fund I, L.P.Inozyme Pharma, Inc.2,804,0626.4%EDGAR
SC 13D/A2023-04-04Pivotal bioVenture Partners Fund I, L.P.Inozyme Pharma, Inc.2,740,0726.3%EDGAR
SC 13G2023-03-07SPHERA FUNDS MANAGEMENT LTD.Inozyme Pharma, Inc.2,096,2585.2%EDGAR
SC 13G/A2023-02-14Venrock Healthcare Capital Partners II, L.P.Inozyme Pharma, Inc.3,867,7499.3%EDGAR
SC 13G/A2023-02-14Deep Track Capital, LPInozyme Pharma, Inc.3,250,0008.0%EDGAR
External links